Drugs / JNJ-440
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03439488 | Mar 2018 → Oct 2019 | chronic hepatitis B virus infection | Alios Biopharma Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-440 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03439488 ↗ |